Onconetix

ONCONasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$2.992 M

$0.68 +4.31%

Close of 22 Sept 2026

Revenue

$815.4K

#3495 by revenue

Earnings

-$14.0M

Loss-making

Shares outstanding

3,949,107

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 499 →

#484Alaunos TherapeuticsTCRT$3.23M
#485Silo PharmaSILO$3.02M
#486OnconetixONCO$2.99M
#487GenprexGNPX$2.90M
#488PRF TechnologiesPRFX$2.83M

What if Onconetix were worth as much as…

Open the what-if tool →

Gold $30.2T

$6,901,909

Per share 10,103,805× higher

Bitcoin $1.74T

$397,590.70

Per share 582,039× higher

Nvidia $5.52T

$1,259,157

Per share 1,843,299× higher

Or at a round number

$5.00M $10.0M $20.0M $50.0M

Where these numbers come from

Share counts and financials for Onconetix are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 23 Sept 2026. Read the methodology.